NANOBIOTIX S.A. SP.ADR (5NRA) — Cash Flow-to-Debt Ratio
Latest as of December 2025:
-0.22x
NANOBIOTIX S.A. SP.ADR (5NRA) has a Cash Flow-to-Debt Ratio of -0.22x as of December 2025, meaning its operating cash flow of €-33.42 Million could theoretically repay 0% of its total liabilities (€152.24 Million) in one year. See 5NRA free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
-0.22x
Operating CF / Total Liabilities
Operating Cash Flow
€-33.42 Million
EUR
Total Liabilities
€152.24 Million
EUR
Data as of
Dec 2025
Most recent filing
NANOBIOTIX S.A. SP.ADR Cash Flow-to-Debt Ratio (2021–2025)
Historical debt coverage capacity for NANOBIOTIX S.A. SP.ADR across 5 annual periods. For the full cash flow conversion analysis, see how efficiently does NANOBIOTIX S.A. SP.ADR generate cash.
Annual Cash Flow-to-Debt Ratio for NANOBIOTIX S.A. SP.ADR (2021–2025)
Year-by-year debt coverage analysis for NANOBIOTIX S.A. SP.ADR.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.22x | €-33.42 Million | €152.24 Million | ▼ -49.5% |
| 2024 | -0.15x | €-19.55 Million | €133.12 Million | ▼ -12.7% |
| 2023 | -0.13x | €-12.48 Million | €95.74 Million | ▲ +69.5% |
| 2022 | -0.43x | €-37.10 Million | €86.81 Million | ▼ -7.3% |
| 2021 | -0.40x | €-29.87 Million | €74.98 Million | — |
Cash Flow-to-Debt Ratio = Operating Cash Flow / Total Liabilities. Higher is better for debt service capacity.